Cardiology update 2017: The first quarter
In the first quarter of 2017, proprotein convertase subtilisin/kexin type 9's role got defined further with a number of trials such as FOURIER, ORION-1, and SPIRE 1 and 2. TAVI proves safe in intermediate-risk patients in the Surgical Replacement and Transcatheter Aortic Valve Implantation study. Ne...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wolters Kluwer Medknow Publications
2017-01-01
|
| coleção: | Journal of the Practice of Cardiovascular Sciences |
| Assuntos: | |
| Acesso em linha: | http://www.j-pcs.org/article.asp?issn=2395-5414;year=2017;volume=3;issue=1;spage=18;epage=21;aulast=Umapathy |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|